【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cutaneous T-Cell Lymphoma 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Cutaneous T-Cell Lymphoma to Oncology Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Cutaneous T-Cell Lymphoma to Oncology Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Cutaneous T-Cell Lymphoma 25
Subjects Recruited Over a Period of Time 30
Clinical Trials by Sponsor Type 31
Prominent Sponsors 32
Top Companies Participating in Cutaneous T-Cell Lymphoma Therapeutics Clinical Trials 33
Prominent Drugs 35
Latest Clinical Trials News on Cutaneous T-Cell Lymphoma 36
Jan 15, 2014: Addition of Japanese Sites for Pivotal Phase 3 Trial of Mogamulizumab in Patients with Cutaneous T-Cell Lymphoma 36
Oct 08, 2013: OncoSec Medical Announces Positive Preliminary Safety Data in Combination Study 36
Jul 24, 2013: Inovio Pharmaceuticals’ Potent hTERT DNA Cancer Vaccine Shows Potential to Reduce Tumors and Prevent Tumor Recurrence 37
Dec 13, 2012: Kyowa Hakko Kirin Initiates Pivotal Phase III Trial Of Mogamulizumab In Patients With Cutaneous T-Cell Lymphoma In US 38
Dec 11, 2012: Kyowa Hakko Kirin Announces Presentation Of Phase II Clinical Trial Results Of Mogamulizumab At ASH Annual Meeting 38
Clinical Trial Profiles 40
Clinical Trial Overview of Top Companies 40
Merck & Co., Inc. 40
Clinical Trial Overview of Merck & Co., Inc. 40
Novartis AG 41
Clinical Trial Overview of Novartis AG 41
Ligand Pharmaceuticals, Inc. 42
Clinical Trial Overview of Ligand Pharmaceuticals, Inc. 42
Eisai Co., Ltd. 43
Clinical Trial Overview of Eisai Co., Ltd. 43
Celgene Corporation 44
Clinical Trial Overview of Celgene Corporation 44
BioCryst Pharmaceuticals, Inc. 45
Clinical Trial Overview of BioCryst Pharmaceuticals, Inc. 45
Takeda Pharmaceutical Company Limited 46
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 46
Kirin Holdings Company, Limited 47
Clinical Trial Overview of Kirin Holdings Company, Limited 47
Emergent BioSolutions Inc. 48
Clinical Trial Overview of Emergent BioSolutions Inc. 48
Eli Lilly and Company 49
Clinical Trial Overview of Eli Lilly and Company 49
Clinical Trial Overview of Top Institutes / Government 50
National Cancer Institute 50
Clinical Trial Overview of National Cancer Institute 50
Fred Hutchinson Cancer Research Center 53
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 53
The University of Texas M. D. Anderson Cancer Center 55
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 55
Northwestern University 56
Clinical Trial Overview of Northwestern University 56
Stanford University 57
Clinical Trial Overview of Stanford University 57
University of Washington 58
Clinical Trial Overview of University of Washington 58
Memorial Sloan Kettering Cancer Center 59
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 59
European Organization for Research and Treatment of Cancer 60
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 60
Case Comprehensive Cancer Center 61
Clinical Trial Overview of Case Comprehensive Cancer Center 61
Mayo Clinic 62
Clinical Trial Overview of Mayo Clinic 62
Five Key Clinical Profiles 63
Appendix 115
Abbreviations 115
Definitions 115
Research Methodology 116
Secondary Research 116
About GlobalData 117
Contact Us 117
Disclaimer 117
Source 118
【レポート販売概要】
■ タイトル：皮膚T細胞リンパ腫：世界の臨床試験レビュー（2014年上半期）■ 英文：Cutaneous T-Cell Lymphoma Global Clinical Trials Review, H1, 2014
■ 発行日：2014年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDHC2011CTIDB
■ 調査対象地域：グローバル
- 世界の永久磁石市場：類型、用途、新開発、産業構造Permanent magnets are a vital part of modern life. They are found in or used to produce almost every modern convenience today, from speakers in mobile phones to the electric motors in hybrid cars; air conditioners and washing machines. Permanent magnets are used increasingly in technological applications, including traveling wave tubes, Hall Effect sensors, high temperature-resistant permanent mag …
- プロバイオティクス（Probiotics）の世界市場予測（～2022年）“The probiotics market is projected to grow at a CAGR of 7.0%”The probiotics market is estimated to be valued at 45.64 billion in 2017, and projected to grow at a CAGR of 7.0%, to reach USD 64.02 billion by 2022. The market is primarily driven by factors such as growing awareness about the benefits of probiotics among customers, rising demand for nutrient-rich feed for animals, and increasing dema …
- 食品産業用パルス電場（PEF）システムの世界市場2020-2024Global Food Industry Pulsed Electric Field (PEF) Systems Market 2020-2024 Technavio has been monitoring the food industry pulsed electric field (PEF) systems market and it is poised to grow by USD 227.52 mn during 2020-2024, progressing at a CAGR of 24% during the forecast period. Our reports on food industry pulsed electric field (PEF) systems market provides a holistic analysis, market size and …
- Novolog (Type 2 Diabetes)：市場予測と分析（～2022）Novolog (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Novolog (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more …
- 多関節ロボットの世界市場予測（～2023年）The articulated robot market (excluding the cost of robotic peripherals, software, and system engineering) is expected to grow from USD 10.92 Billion in 2018 to USD 23.51 Billion by 2023, at a CAGR of 16.58% during the forecast period. The articulated robot market is expected to register a shipment of 245,012 units in 2018 and is expected to reach 548,566 units by 2023, at a CAGR of 17.49% during …
- アイスクリーム食品市場：シエラレオネ（～2017）Synopsis "Ice Cream Market in Sierra Leone: Databook to 2017" is the result of Canadean's extensive market research covering the Ice Cream market in Sierra Leone. The report presents detailed historic and forecast data on the Ice Cream consumption trends in Sierra Leone, offering consumption volume and value at market and category level. Bringing together Canadean's research, modeling, and analysi …
- 可変風量装置（VAV）の世界市場予測：単一ダクトVAV、二重ダクトVAV、誘導VAV、ファンVAVThe global Variable Air Volume (VAV) systems market, in terms of value, is projected to reach USD 13.44 Billion by 2021, at a CAGR of 6.56% from 2016 to 2021. High demand for VAV systems which are used in HVAC systems, in the emerging economies of the Asia-Pacific region and the Middle East & Africa, and expansions and new product development activities undertaken by different companies, are the k …
- 世界のバイオ農薬（微生物農薬）市場：バイオ殺虫剤、バイオ殺菌剤、バイオ殺線虫剤、バイオ除草剤などBiopesticides are less toxic than conventional pesticides. Biopesticides generally affect only the target pest and closely related organisms, in contrast to broad spectrum, conventional pesticides that may affect organisms as different as birds, insects, and mammals. Biopesticides often are effective in very small quantities and often decompose quickly, thereby resulting in lower exposures and lar …
- 埋め込み型医療デバイスの世界市場：乳房インプラント、歯科インプラント、顔面インプラントAbout implantable medical devices Implantable medical devices are artificial implants used to replace, augment, or repair damaged tissues or organs. They are used in a wide range of applications including cosmetic, spinal, cardiovascular, ophthalmic, and neuro-stimulator implantation surgeries. These implants are made of different materials such as polymers, metals, ceramics, and biologics. Techna …
- ポリマーエマルジョン市場（グローバル動向と予測）This report on Emulsion Polymers (EP) includes four different types of waterborne polymers. These include acrylic emulsions, Vinyl emulsions, SB latex, and others. EPs are substituting solvent borne polymers because of its superior physical and chemical properties. The VOC and VAC content of EPs is low. This makes emulsion polymer an environmentally preferred specialty chemical. EPs are majorly us …
- 解剖病理学の世界市場予測（～2021）：装置（組織処理システム、ミクロトーム）、消耗品（試薬、抗体）、組織病理学、細胞病理学The global anatomic pathology market is segmented on the basis of product & service and application. Anatomic pathology involves the diagnosis of various types of cancer, infectious diseases, and medical conditions through the examination of cells and tissue samples, which are collected from patients through biopsy. The market is witnessing high growth due to factors such as increasing prevalence …
- Obesity Therapeutics to 2019 – Safety Concerns Hinder Drug Performance Despite Large Market OpportunityObesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity Summary GBI Research, the leading business intelligence provider, has released its latest research, “Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity”. Obesity is often described as a global endemic, with incidence dramatically increasing ov …
- 航空機向けサイバーセキュリティの世界市場2016-2020About the Aviation Cyber Security Market The introduction of new technologies without robust cyber security measures presents a risk to the aviation industry. The risk is due to the cyber threats that are likely to increase during the forecast period. The aviation industry stakeholders such as cargo firms, airports, and airlines must recognize the risks to their networks and control systems from c …
- クラウド型統合プラットフォームサービスの世界市場予測（～2021年）The Integration Platform as a Service market is expected to grow from USD 528.0 Million in 2016 to USD 2,998.3 Million by 2021, at a Compound Annual Growth Rate (CAGR) of 41.5% during the forecast period. The demand for iPaaS is driven by factors such as the need for business agility, faster deployment & scalability, increasing awareness about iPaaS among enterprises globally, and reduced cost of …
- 世界のスポーツ装備（用品）動向（2012-2016）TechNavio's analysts forecast the Global Sports Equipment market to grow at a CAGR of 2.38 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing participation in sporting activities. The Global Sports Equipment market has also been witnessing the increasing use of carbon fiber in sports equipment. However, the increasing availability of coun …
